Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2024-09-12 00:00:00 ET · period of report 2024-09-11 · accession 0001415889-24-023313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | 2024-09-11 | PMVP | Jalota Deepika | Chief Development Off | S - Sale | $1.50 | -7,218 | 118.3K | -6% | -$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-11 | S | D | 7,218 | $1.50 | 118,283 | D | — | — |